Back to Search
SURASAK PHUPHANICH, M.D.
M.D.
Neurology Physician
NPI: 1457469074Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
PMID 18477765·Neuro Oncol·2008
5-case
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
PMID 16941075·J Neurooncol·2007
3-trial
Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
PMID 16773214·J Neurooncol·2007
5-case
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study.
PMID 15831235·Neuro Oncol·2005
3-trial
Delivery systems and molecular targets of mechanism-based therapies for GBM.
PMID 15853584·Expert Rev Neurother·2004
6-review
DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
PMID 19432816·J Cell Mol Med·2010
8-other
Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.
PMID 18679580·J Neurooncol·2008
3-trial
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
PMID 18577560·Neuro Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 127 South San Vicente BLVD, Suite A6600, Cedars-Sinai Medical Center-AHSP
Los Angeles, CA 90048 - Phone
- (310) 423-8100
Quick Facts
- NPI
- 1457469074
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile